Acute Cholecystitis. Acute cholecystitis
Conditions
Interventions
Intervention 1: Intervention group: Ursodeoxycholic acid tablets with a dose of 9-10 mg/kg produced by Exir Pharmacy, will be taken orally at bedtime once a day. The duration of treatment is six weeks
Sponsors
Zanjan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patient diagnosed with acute cholecystitis and candidate for delayed surgery (patients who did not present within the first 72 hours of onset) Patients who are not candidates for early surgery due to other medical problems such as severe congestive heart failure. Patient's personal consent to attend the study Stone size less than 15 mm Patients with mild symptoms or asymptomatic
Exclusion criteria
Exclusion criteria: Patients who are unable to tolerate ursodeoxycholic acid Patients with complicated gallstones Patients with cholangitis Patients with impaired liver tests Patients with moderate to severe symptoms Patients who become candidates for emergency surgery before the sixth week during the waiting period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patients' pain while waiting for cholecystectomy surgery. Timepoint: Patients' pain will be assessed at baseline and at 3 and 6 weeks after starting treatment. Method of measurement: Based on Visual Analogue Scale scale, data would be collected. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNaser Keikhali
Zanjan University of Medical Sciences
Outcome results
None listed